Skip to content

Enclomiphene

Enclomiphene (Androxal) appears in two listed tablets, Enclomisign and the named brand. Both are associated with secondary hypogonadism and contain the same oestrogen-antagonist ingredient. Their brand, selected strength and formulation details provide the principal points of comparison. Listed products differ in ingredient profile, form, strength, and pack size.

Enclomisign

Secondary Hypogonadism

50mg

Designed to support ovulation recruitment to manage fertility pathways and alleviate reproductive hormone deficits.

From$1.83/ tabletView

Androxal

Secondary Hypogonadism

50mg

Designed to support testosterone synthesis to manage endocrine balance and alleviate symptoms of hypogonadism.

From$1.14/ tabletView

What is enclomiphene used for?

An oestrogen receptor antagonist, enclomiphene alters hormonal feedback signals involved in testosterone production. The two tablets have recorded use for Secondary Hypogonadism. Their place within Hormone Therapy reflects this endocrine role.

Important safety information for Enclomiphene

Information about Enclomiphene on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.